hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases

Summary

To evaluate the safety and preliminary efficacy of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles hUC-MSC-sEV-001 nasal drops in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple system atrophy, Lewy body dementia, frontotemporal dementia, and amyotrophic lateral sclerosis.

Timeline

Start

2025-07-01

Primary completion

2027-08-31

Completion

2028-08-31

Drugs

Indications